327 related articles for article (PubMed ID: 23308245)
1. Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression.
Shukla S; Sharma H; Abbas A; MacLennan GT; Fu P; Danielpour D; Gupta S
PLoS One; 2013; 8(1):e53527. PubMed ID: 23308245
[TBL] [Abstract][Full Text] [Related]
2. SATB1 promotes prostate cancer metastasis by the regulation of epithelial-mesenchymal transition.
Mao LJ; Yang CH; Fan L; Gao P; Yang DR; Xue BX; Zheng JN; Shan YX
Biomed Pharmacother; 2016 Apr; 79():1-8. PubMed ID: 27044805
[TBL] [Abstract][Full Text] [Related]
3. Multiple effects of the special AT-rich binding protein 1 (SATB1) in colon carcinoma.
Frömberg A; Rabe M; Aigner A
Int J Cancer; 2014 Dec; 135(11):2537-46. PubMed ID: 24729451
[TBL] [Abstract][Full Text] [Related]
4. SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion.
Mao L; Yang C; Wang J; Li W; Wen R; Chen J; Zheng J
J Transl Med; 2013 May; 11():111. PubMed ID: 23642278
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic virus carrying shRNA targeting SATB1 inhibits prostate cancer growth and metastasis.
Mao LJ; Zhang J; Liu N; Fan L; Yang DR; Xue BX; Shan YX; Zheng JN
Tumour Biol; 2015 Nov; 36(11):9073-81. PubMed ID: 26084613
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
7. Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.
Frömberg A; Rabe M; Oppermann H; Gaunitz F; Aigner A
BMC Cancer; 2017 Jan; 17(1):3. PubMed ID: 28049521
[TBL] [Abstract][Full Text] [Related]
8. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
Zhou D; Ye C; Pan Z; Deng Y
Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
[No Abstract] [Full Text] [Related]
9. SATB1 3'-UTR and lncRNA-UCA1 competitively bind to miR-495-3p and together regulate the proliferation and invasion of gastric cancer.
Sun L; Liu L; Yang J; Li H; Zhang C
J Cell Biochem; 2019 Apr; 120(4):6671-6682. PubMed ID: 30368875
[TBL] [Abstract][Full Text] [Related]
10. Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer.
Fang XF; Hou ZB; Dai XZ; Chen C; Ge J; Shen H; Li XF; Yu LK; Yuan Y
World J Gastroenterol; 2013 Apr; 19(15):2331-9. PubMed ID: 23613626
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
Murali AK; Norris JS
J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
[TBL] [Abstract][Full Text] [Related]
12. ATM suppresses SATB1-induced malignant progression in breast epithelial cells.
Ordinario E; Han HJ; Furuta S; Heiser LM; Jakkula LR; Rodier F; Spellman PT; Campisi J; Gray JW; Bissell MJ; Kohwi Y; Kohwi-Shigematsu T
PLoS One; 2012; 7(12):e51786. PubMed ID: 23251624
[TBL] [Abstract][Full Text] [Related]
13. TRPM4 channel is involved in regulating epithelial to mesenchymal transition, migration, and invasion of prostate cancer cell lines.
Sagredo AI; Sagredo EA; Pola V; Echeverría C; Andaur R; Michea L; Stutzin A; Simon F; Marcelain K; Armisén R
J Cell Physiol; 2019 Mar; 234(3):2037-2050. PubMed ID: 30343491
[TBL] [Abstract][Full Text] [Related]
14. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
15. Expression of SATB1 promotes the growth and metastasis of colorectal cancer.
Zhang Y; Tian X; Ji H; Guan X; Xu W; Dong B; Zhao M; Wei M; Ye C; Sun Y; Yuan X; Yang C; Hao C
PLoS One; 2014; 9(6):e100413. PubMed ID: 24971456
[TBL] [Abstract][Full Text] [Related]
16. SATB1 overexpression regulates the development and progression in bladder cancer through EMT.
Wan F; Cheng C; Wang Z; Xiao X; Zeng H; Xing S; Chen X; Wang J; Li S; Zhang Y; Xiang W; Zhu Z; Johnson C; Zhu Z
PLoS One; 2015; 10(2):e0117518. PubMed ID: 25706386
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
18. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer.
Li H; Kim C; Liu W; Zhu J; Chin K; Rodriguez-Canales J; Rodgers GP
Int J Cancer; 2020 Mar; 146(5):1346-1358. PubMed ID: 31241767
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
[TBL] [Abstract][Full Text] [Related]
20. microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer.
Bhagirath D; Yang TL; Bucay N; Sekhon K; Majid S; Shahryari V; Dahiya R; Tanaka Y; Saini S
Cancer Res; 2018 Apr; 78(7):1833-1844. PubMed ID: 29437039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
